Navigation Links
Narcolepsy Drug Might Be Addictive
Date:3/17/2009

Finding comes as use of stimulant for enhanced mental function is on the increase

TUESDAY, March 17 (HealthDay News) -- A drug used to treat narcolepsy is increasingly being taken to sharpen mental skills, but researchers now report troubling evidence that it also harbors the potential for abuse.

Modafinil (Provigil) apparently alters the dopamine "reward system" in the brain, the new study shows.

"This drug does seem to show properties that it can be habit-forming," said Dr. Richard A. Friedman, director of the Psychopharmacology Clinic at Weill Cornell Medical College in New York City. "This is the first human study that shows that it does cause the release of dopamine, which is a hallmark of drugs of addiction. This is a little bit of an early warning that this drug may not be free of habit-forming properties."

Friedman also said that he had used the drug for treatment-resistant depression and in people who have circadian rhythm problems who have commonly reported that "they feel really good."

"It's important that these medications be utilized under the proper surveillance of a physician," said Dr. Nora D. Volkow, director of the National Institute on Drug Abuse. "If you're taking modafinil without a medical indication, then the risk-benefit ratio becomes very different."

Volkow is lead author of a paper on the finding in the March 18 issue of the Journal of the American Medical Association.

In addition to being used for sleeping disorders, modafinil is also used to boost cognitive functioning in individuals with schizophrenia and attention-deficit/hyperactivity disorder (ADHD).

This new finding suggests that the drug may work more like stimulants such as methylphenidate (Ritalin) and amphetamine than previously thought. These drugs, used to treat ADHD, increase dopamine levels.

And now people are also buying it without a prescription, on the Internet or from France, Volkow said.

Animal studies had indicated that the drug does not work the same way as other stimulant medications, but lately evidence has emerged suggesting that is not the case.

The authors used PET scans to study the effect of modafinil on the brains of 10 healthy men aged 23 to 46. Participants received either 200 milligrams of the drug (recommended for narcolepsy), 400 milligrams of the drug (effective for ADHD), or a placebo.

"We were interested in seeing if modafinil increased concentrations of dopamine in the brain reward areas, because that's where all the concern around stimulant medication and addictive potential lies," Volkow said.

In fact, the drug did raise dopamine levels in the brain and, particularly, in the nucleus accumbens region, a "pleasure center" of the brain.

"The data are consistent with what we've known about modafinil for 16 years, that it was a very, very weak inhibitor of dopamine uptake," said Jeffry Vaught, chief scientific officer and executive vice president of Cephalon Inc., which makes the medication. "At its launch, we worked with several groups to track the illicit use of modafinil and evaluate any misuse or abuse. The conclusions continually have been that, if there is any, it is very limited. Could this be part of the drug's mechanism? Maybe. Does it explain the mechanism? I don't think so, and I don't think it changes the abuse liability we've tracked now for some 15 years."

More information

Visit the U.S. National Institute on Drug Abuse for more on addiction.



SOURCES: Nora D. Volkow, M.D., director, National Institute on Drug Abuse, Bethesda, Md.; Richard A. Friedman, M.D., director, Psychopharmacology Clinic, and professor, clinical psychiatry, Weill Cornell Medical College, New York City; Jeffry Vaught, Ph.D., chief scientific officer and executive vice president, Cephalon Inc., Frazer, Pa.; March 18, 2009, Journal of the American Medical Association


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Publication Provides a Wake-Up Call For Clinicians Treating Narcolepsy
2. Lower metabolism, eating behavior possibly explain the cause of overweight in narcolepsy
3. Hormone Might Help Restore Female Fertility
4. Combo of Tests Might Spot Ovarian Cancer Early
5. Sunburn Might Play a Role in Rosacea
6. Technique Might Prevent Some Bladder Removals
7. New staging technique might save bladders in some bladder cancer patients
8. Germicide Might Guard Against HIV Infection
9. Tests Might Diagnose, Predict Prostate Cancer
10. B Vitamins Might Lower Stroke Risk
11. Empathy Might Be in the Genes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Narcolepsy Drug Might Be Addictive
(Date:1/17/2017)... York, NY (PRWEB) , ... January 17, 2017 ... ... Inc. Magazine’s fastest-growing private companies and ranked among the top US security companies ... Board of Directors. This announcement brings a year-long independent board nomination process ...
(Date:1/17/2017)... ... January 17, 2017 , ... Twelve (12) years ... Athletic Training Education program forged a relationship built upon the foundation of sports ... is consists of both student members and certified members of the Athletic Trainers’ ...
(Date:1/16/2017)... ... January 16, 2017 , ... California Southern University has named Dr. ... CalSouthern’s Board of Trustees and as a core faculty member, teaching master’s and doctoral ... professor of psychology at Pepperdine University, where he earned his Doctor of Psychology degree ...
(Date:1/16/2017)... ... 2017 , ... With the Grand Opening Event planned for February 3, 2017, ... teams and the general public. Built in five months by Centerpoint, the 60,000 square ... basketball or pickleball courts. The space is also suitable for indoor soccer and football ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... announced the addition of Victor Giamos, MD to their medical staff, according to ... Partner at North Shore Eye Care, a division of SightMD. Dr. Giamos will ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Interpace Diagnostics Group, Inc., (NASDAQ: ... diagnostic tests and pathology services for evaluating risks of ... dated January 13, 2017 from the NASDAQ Listing Qualifications ... the requirement of the NASDAQ Stock Market to maintain ... The letter noted that for the last ...
(Date:1/17/2017)... and Markets has announced the addition of the "The Top 200 ... ... profiles the leading 200 manufacturers and distributors of molecular diagnostics products worldwide. ... States and Europe to ... Profile information for each company in The Top 200 Molecular Diagnostics Companies ...
(Date:1/17/2017)... Catherine Amey ; ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Neurological Review , the ... reports that despite standard care, temperatures exceeding 37.5°C ...
Breaking Medicine Technology: